Chris Hagen, President of SCIEX, shares his vision for the company and introduces the new ZenoTOF 8600 system, featuring electron activated dissociation (EAD) that provides more complete molecule identification and characterization and ZTScan for enhanced Q1 window selectivity.

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Video Interview With Chris Hagen, President of SCIEX

Newsletter